Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero for prevention of gonorrhea infection
NCT05294588Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2022
- Primary completion
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group B vaccine in gonorrhea, sponsored by University of North Carolina at Chapel Hill. Started Apr 2022; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT05294588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05294588.